Clinical Advisory Board
The Clinical Advisory Board brings together leading physicians and researchers with deep expertise across organ transplantation, transplant immunology and immunosuppression. Members will help advise LifeMine on the ongoing clinical development of LIFE-001, a structurally and mechanistically novel calcineurin activation inhibitor (CNai) delivered as a long-acting injectable and designed de novo to avoid the immunophilin-dependent organ damage common to all legacy calcineurin inhibitors (CNis) such as cyclosporin, voclosporin and tacrolimus.
- Andrew Cameron, M.D.
- Surgeon-in-Chief, Johns Hopkins Hospital
- Andrew Adams, M.D.
- Professor and Chief, Division of Transplantation, University of Minnesota
- Roy Bloom, M.D.
- Medical Director, University of Pennsylvania Hospital
- Beatrice Concepcion, M.D.
- Medical Director, University of Chicago Medicine
- John Gill, M.D.
- Professor of Medicine and Academic Head Kidney Transplantation, University of British Columbia
- Nicolae Leca, M.D.
- Medical Director, University of Washington Medical Center
- Roslyn Mannon, M.D.
- Vice Chair of Research Internal Medicine, Associate Chief of Research Nephrology, University of Nebraska Medical Center
- Flavio Vincenti, M.D.
- Specialist, Kidney & Pancreas Transplantation, UC San Francisco Medical Center
